Smiles
O=C(OC(C)(C)C)N[C@@H](CCCCN/C(NCC)=N/CC)C(N[C@@H](CC(C)C)C(N[C@H](C(N1[C@H](C(N[C@H](C)C(N)=O)=O)CCC1)=O)CCCCN/C(NCC)=N/CC)=O)=O
Therapeutic Uses
Synthetic Peptides
Storage Condition
Store at refrigerator (2-8°C) for long term storage
IUPAC Name
tert-butyl ((3E,10S,13S,16S,22E)-10-((S)-2-(((R)-1-amino-1-oxopropan-2-
yl)carbamoyl)pyrrolidine-1-carbonyl)-4,22-bis(ethylamino)-13-isobutyl-12,15-dioxo3,5,11,14,21,23-hexaazapentacosa-3,22-dien-16-yl)carbamate
Synonyms
tert-butyl ((3E,10S,13S,16S,22E)-10-((S)-2-(((R)-1-amino-1-oxopropan-2-
yl)carbamoyl)pyrrolidine-1-carbonyl)-4,22-bis(ethylamino)-13-isobutyl-12,15-dioxo3,5,11,14,21,23-hexaazapentacosa-3,22-dien-16-yl)carbamate
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90%
Hazard Compound
Refer MSDS for accurate information
Useful research chemical for a range of applications
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Ganirelix Impurity C usage and description
Ganirelix is a gonadotropin-releasing hormone antagonist that is primarily used in in vitro fertilization (IVF) to prevent premature ovulation. Ganirelix Impurity C is a byproduct that is formed during the synthesis of ganirelix. It is important to understand the chemical properties and potential effects of this impurity as it can impact the efficacy and safety of ganirelix.
Ganirelix Impurity C is a small organic molecule with a molecular weight of 431.5 g/mol. It is a non-peptide compound and is not an analogue of gonadotropin-releasing hormone. The chemical structure of this impurity is not publicly available, but it is known to be a polar compound that is soluble in both water and organic solvents.
The presence of Ganirelix Impurity C can impact the purity and potency of ganirelix. It is recommended that the impurity content in ganirelix be kept below 0.5%. High levels of impurities can decrease the effectiveness of the drug and increase the risk of adverse effects.
In conclusion, Ganirelix Impurity C is a byproduct of ganirelix synthesis that can impact the quality and safety of the drug. It is important to monitor and control impurity levels to ensure the effectiveness of ganirelix in IVF treatment.
